Investors

<p>Close up of a middle aged woman dressed in a blazer, sitting down while looking at another person in the foreground.</p>

Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.

Events & Presentations

    2023

    2023

    Previous

    CEO Erik Manting gives interview to Edison ahead of Mendus’s presentation of updated vididencel survivability data at ASH 2023

    Learn more
    Previous

    Interview with CEO Erik Manting

    CEO Erik Manting presents at Redeye Life Science Day 2023 – 23 November
    Learn more
    Previous

    Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

    Mendus will present data from the ongoing Phase 1 ALISON trial in ovarian cancer at SITC 2023. Full abstracts are expected to be published online on Oct. 31, 2023.
    Learn more
    Previous

    HealthTech Innovation Days

    Mendus CEO Erik Manting and CFO Lotta Ferm will participate and present a Company Update at the conference.
    Learn more
    Previous

    Interview with CEO Erik Manting

    Mendus’ CEO Erik Manting is commenting on the latest development in the company
    Learn more
    Previous

    Innate Killer Summit Europe

    Mendus CTO Leopold Bertea will participate and present the Company at the conference.
    Learn more
    Previous

    LSX Nordic Congress

    Mendus CEO Erik Manting and CFO Lotta Ferm will participate and present a Company Update at the conference.
    Learn more
    Previous

    Nordic Conference and Opening Ceremony of NorthX Innovation Hub

    Mendus Board member Hans Preusting will participate at the event.
    Learn more
    Previous

    CICON23 – International Cancer Immunotherapy Conference

    Mendus to present preclinical and clinical data on the mode of action of its lead clinical program vididencel.
    Learn more
    Previous

    Pareto Securities’ Annual Healthcare Conference

    Mendus CEO Erik Manting and CFO Lotta Ferm will participate and present a Company Update at the conference.
    Learn more